Profile of acotiamide in the treatment of functional dyspepsia

Masahiro Ueda; Eisuke Iwasaki; Hidekazu Suzuki

doi:10.2147/CEG.S72172

Profile of acotiamide in the treatment of functional dyspepsia

Masahiro Ueda, Eisuke Iwasaki, Hidekazu Suzuki

Research output: Contribution to journal › Review article › peer-review

16 Citations (Scopus)

Abstract

Efficacy of acotiamide for improving symptoms in patients with functional dyspepsia was shown by several clinical trials. In a randomized, double-blind, placebo-controlled, parallel-group comparative Phase III trial conducted in Japan, 100 mg of acotiamide three times a day for 4 weeks was more effective than a placebo for improving symptoms, and quality of life. Acotiamide was well-tolerated treatment, with no significant adverse events. The aim of this review was to summarize the current evidence of the efficacy of acotiamide in the treatment of patients with functional dyspepsia.

Original language	English
Pages (from-to)	83-88
Number of pages	6
Journal	Clinical and Experimental Gastroenterology
Volume	9
DOIs	https://doi.org/10.2147/CEG.S72172
Publication status	Published - 2016 Apr 6

Keywords

Acetylcholinesterase
Acotiamide
Functional dyspepsia
Rome III

ASJC Scopus subject areas

Gastroenterology

Access to Document

10.2147/CEG.S72172

Cite this

@article{1ba940701d12444ea5427955f180b0e0,

title = "Profile of acotiamide in the treatment of functional dyspepsia",

abstract = "Efficacy of acotiamide for improving symptoms in patients with functional dyspepsia was shown by several clinical trials. In a randomized, double-blind, placebo-controlled, parallel-group comparative Phase III trial conducted in Japan, 100 mg of acotiamide three times a day for 4 weeks was more effective than a placebo for improving symptoms, and quality of life. Acotiamide was well-tolerated treatment, with no significant adverse events. The aim of this review was to summarize the current evidence of the efficacy of acotiamide in the treatment of patients with functional dyspepsia.",

keywords = "Acetylcholinesterase, Acotiamide, Functional dyspepsia, Rome III",

author = "Masahiro Ueda and Eisuke Iwasaki and Hidekazu Suzuki",

note = "Publisher Copyright: {\textcopyright} 2016 Ueda et al.",

year = "2016",

month = apr,

day = "6",

doi = "10.2147/CEG.S72172",

language = "English",

volume = "9",

pages = "83--88",

journal = "Clinical and Experimental Gastroenterology",

issn = "1178-7023",

publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Profile of acotiamide in the treatment of functional dyspepsia

AU - Ueda, Masahiro

AU - Iwasaki, Eisuke

AU - Suzuki, Hidekazu

PY - 2016/4/6

Y1 - 2016/4/6

N2 - Efficacy of acotiamide for improving symptoms in patients with functional dyspepsia was shown by several clinical trials. In a randomized, double-blind, placebo-controlled, parallel-group comparative Phase III trial conducted in Japan, 100 mg of acotiamide three times a day for 4 weeks was more effective than a placebo for improving symptoms, and quality of life. Acotiamide was well-tolerated treatment, with no significant adverse events. The aim of this review was to summarize the current evidence of the efficacy of acotiamide in the treatment of patients with functional dyspepsia.

AB - Efficacy of acotiamide for improving symptoms in patients with functional dyspepsia was shown by several clinical trials. In a randomized, double-blind, placebo-controlled, parallel-group comparative Phase III trial conducted in Japan, 100 mg of acotiamide three times a day for 4 weeks was more effective than a placebo for improving symptoms, and quality of life. Acotiamide was well-tolerated treatment, with no significant adverse events. The aim of this review was to summarize the current evidence of the efficacy of acotiamide in the treatment of patients with functional dyspepsia.

KW - Acetylcholinesterase

KW - Acotiamide

KW - Functional dyspepsia

KW - Rome III

UR - http://www.scopus.com/inward/record.url?scp=84962684467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962684467&partnerID=8YFLogxK

U2 - 10.2147/CEG.S72172

DO - 10.2147/CEG.S72172

M3 - Review article

AN - SCOPUS:84962684467

SN - 1178-7023

VL - 9

SP - 83

EP - 88

JO - Clinical and Experimental Gastroenterology

JF - Clinical and Experimental Gastroenterology

ER -

Profile of acotiamide in the treatment of functional dyspepsia

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this